Rose SL - Search Results

1

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.

Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Alberts DS, et al. Among authors: rose sl. Gynecol Oncol. 2012 Dec;127(3):451-5. doi: 10.1016/j.ygyno.2012.09.008. Epub 2012 Sep 14. Gynecol Oncol. 2012. PMID: 22986144 Free PMC article. Clinical Trial.

2

Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.

Dunn EF, Geye H, Platta CS, Gondi V, Rose S, Bradley KA, Anderson BM. Dunn EF, et al. Gynecol Oncol. 2014 Jun;133(3):494-8. doi: 10.1016/j.ygyno.2014.03.554. Epub 2014 Mar 20. Gynecol Oncol. 2014. PMID: 24657301

3

Transversus abdominis plane block in robotic gynecologic oncology: a randomized, placebo-controlled trial.

Hotujec BT, Spencer RJ, Donnelly MJ, Bruggink SM, Rose SL, Al-Niaimi A, Chappell R, Stewart SL, Kushner DM. Hotujec BT, et al. Among authors: rose sl. Gynecol Oncol. 2015 Mar;136(3):460-5. doi: 10.1016/j.ygyno.2014.11.013. Epub 2014 Nov 20. Gynecol Oncol. 2015. PMID: 25462201 Clinical Trial.

4

Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?

Vetter MH, Smrz S, Gehrig PA, Peng K, Matsuo K, Davidson BA, Cisa MP, Lees BF, Brunette LL, Tucker K, Stuart Staley A, Gotlieb WH, Holloway RW, Essel KG, Holman LL, Goldfeld E, Olawaiye A, Rose S, Uppal S, Bixel K. Vetter MH, et al. Gynecol Oncol. 2020 Nov;159(2):354-358. doi: 10.1016/j.ygyno.2020.08.004. Epub 2020 Sep 2. Gynecol Oncol. 2020. PMID: 32888724

5

Notch 1 signaling is active in ovarian cancer.

Rose SL, Kunnimalaiyaan M, Drenzek J, Seiler N. Rose SL, et al. Gynecol Oncol. 2010 Apr;117(1):130-3. doi: 10.1016/j.ygyno.2009.12.003. Epub 2010 Jan 8. Gynecol Oncol. 2010. PMID: 20060575

6

Survivors of endometrial cancer: who is at risk for sexual dysfunction?

Onujiogu N, Johnson T, Seo S, Mijal K, Rash J, Seaborne L, Rose S, Kushner DM. Onujiogu N, et al. Gynecol Oncol. 2011 Nov;123(2):356-9. doi: 10.1016/j.ygyno.2011.07.035. Gynecol Oncol. 2011. PMID: 21855974

7

Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies.

Uppal S, Al-Niaimi A, Rice LW, Rose SL, Kushner DM, Spencer RJ, Hartenbach E. Uppal S, et al. Among authors: rose sl. Gynecol Oncol. 2013 Nov;131(2):416-22. doi: 10.1016/j.ygyno.2013.08.011. Epub 2013 Aug 17. Gynecol Oncol. 2013. PMID: 23962700

8

Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients.

Al-Niaimi AN, Ahmed M, Burish N, Chackmakchy SA, Seo S, Rose S, Hartenbach E, Kushner DM, Safdar N, Rice L, Connor J. Al-Niaimi AN, et al. Gynecol Oncol. 2015 Jan;136(1):71-6. doi: 10.1016/j.ygyno.2014.09.013. Epub 2014 Sep 28. Gynecol Oncol. 2015. PMID: 25263249 Free PMC article.

9

Frailty index predicts severe complications in gynecologic oncology patients.

Uppal S, Igwe E, Rice LW, Spencer RJ, Rose SL. Uppal S, et al. Among authors: rose sl. Gynecol Oncol. 2015 Apr;137(1):98-101. doi: 10.1016/j.ygyno.2015.01.532. Epub 2015 Jan 17. Gynecol Oncol. 2015. PMID: 25602715

10

Symptom management of gynecologic cancers: refocusing on the forest.

Cleeland CS, Rose SL. Cleeland CS, et al. Among authors: rose sl. Gynecol Oncol. 2015 Mar;136(3):413-4. doi: 10.1016/j.ygyno.2015.01.555. Gynecol Oncol. 2015. PMID: 25752571 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters